| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |